Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Consumer Products Africa.
Press releases published on September 7, 2025

Faruqi & Faruqi Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 - CNC
Faruqi …

Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCY
Faruqi …

Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 - SLQT
Faruqi …

Faruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANRO
Faruqi …

KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of KBR, Inc. (NYSE: KBR) resulting from allegations that KBR may have issued …

Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST
Faruqi …

Faruqi & Faruqi Reminds PubMatic Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 20, 2025 - PUBM
Faruqi …

Faruqi & Faruqi Reminds Flywire Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2025 - FLYW
Faruqi …

Faruqi & Faruqi Reminds Semler Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR
Faruqi …

Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT
Faruqi …

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations …

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Faruqi …

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 - IRBT
Faruqi …

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: …

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres
BERLIN, Sept. 07, 2025 (GLOBE NEWSWIRE) -- HKC Group, a global display manufacturer, makes its European debut at IFA 2025 with a coordinated showcase across its three brands—HKC, KOORUI, and ANTGAMER—each unveiling a breakthrough product. The move …

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing
Salt Lake City, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only and does not provide medical advice. Some links in this article may be promotional affiliate links. If readers click on these links and complete a …

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands
New York, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration …